MedPath

Fat Reduction Induced by Magnetic Device - Ultrasonographic Evaluation

Not Applicable
Withdrawn
Conditions
Fat Burn
Interventions
Device: Treatment with High Intensity Focused ElectroMagnetic system
Registration Number
NCT03537716
Lead Sponsor
BTL Industries Ltd.
Brief Summary

The study is a prospective multi-center open-label single-arm study. The subjects will be enrolled and assigned into a single study group. Subjects will be required to complete four (4) treatment visits and four follow-up visits, 1 month, 3, 6 and 12 months after the final treatment.

At the baseline visit photographs of the abdomen will be taken. In addition, adipose/muscle layer thickness will be measured with the ultrasound and the subject's weight will be recorded. In addition, at the last therapy visit, subjects will receive Subject Satisfaction and Therapy Comfort Questionnaires to fill in.

Safety measures will include documentation of adverse events (AE) including subject's experience of pain or discomfort after the procedure. Following each treatment administration and at the follow-up visits, subjects will be checked for immediate post-procedure adverse event assessment.

Post-procedure evaluation (follow-up visits) will be conducted 1 month, 3, 6 and 12 months after the final treatment. An ultrasound imaging and weight measure will be conducted. Also, subject's satisfaction will be noted. During the first (1 month), third (6 months) and last (12 months) follow-up visits, photographs of abdomen will be taken.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Adult subjects of both genders with unwanted abdominal fat and expressing interest in treatment
  • Age ≥ 22 years
  • Voluntarily signed informed consent form
  • BMI ≤ 30 kg/m2
Exclusion Criteria
  • Cardiac pacemakers
  • Electronic implants
  • Pulmonary insufficiency
  • Metal implants
  • Drug pumps
  • Haemorrhagic conditions
  • Anticoagulation therapy
  • Heart disorders
  • Malignant tumor
  • Fever
  • Pregnancy
  • Breastfeeding
  • Following recent surgical procedures when muscle contraction may disrupt the healing process
  • Application over menstruating uterus
  • Application over areas of the skin which lack normal sensation
  • Scars, open lesions and wounds at the treatment area
  • Unrepaired abdominal hernia

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Treatment GroupTreatment with High Intensity Focused ElectroMagnetic systemTreatment with the investigational device - High Intensity Focused ElectroMagnetic system
Primary Outcome Measures
NameTimeMethod
Effectiveness of the device assessed through photographic evaluation13 months

Photographic evaluations with correct identification of pre-treatment images compared to post-treatment images.

Effectiveness of the device assessed through change in adipose layer thickness13 months

Change in adipose layer thickness between pre-treatment and post-treatment based on ultrasound measurements

Subject's satisfaction13 months

The 5-point Likert scale Subject Satisfaction Questionnaire will be used for an analysis of the subject's opinion of the therapy results. Subjects will be evaluating agreement with three different statements (concerning satisfaction with therapy results and appearance of abdominal area after therapy) by choosing an answer on a scale between 1 (Strongly disagree) and 5 (Strongly agree). Minimally 80% of the treated subjects should report the agreement with all three statements given in the questionnaire (answers "Agree" and "Strongly agree") in order to claim subject's satisfaction with the therapy outcome.

Secondary Outcome Measures
NameTimeMethod
Safety of the device for non-invasive fat disruption13 months

The secondary objective of the study is to determine side effects and adverse events (AE) associated with the treatment of the abdominal area.

The occurrence of adverse events will be followed throughout the whole study.

Therapy comfort3 months

Therapy comfort will be noted at the last therapy visit.

Trial Locations

Locations (3)

JUVA Skin & Laser Center

🇺🇸

New York, New York, United States

Center for SmartLipo and Plastic Surgery

🇺🇸

Langhorne, Pennsylvania, United States

Dermasense Dermatology Clinic

🇧🇬

Burgas, Bulgaria

© Copyright 2025. All Rights Reserved by MedPath